Natural killer cells control a T-helper 1 response in patients with Behçet's disease

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Yamaguchi, Yukie ^a,b   Takahashi, Hayato ^a   Satoh, Takashi ^a   Okazaki, Yuka ^a   Mizuki, Nobuhisa ^b   Takahashi, Kazuo ^b   Ikezawa, Zenro ^b   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD69 ANTIGEN; COLCHICINE; CYCLOSPORIN; ETANERCEPT; GAMMA INTERFERON; GRANZYME B; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 13; MESSENGER RNA; METHOTREXATE; PERFORIN; PREDNISOLONE; STAT4 PROTEIN; INTERLEUKIN 12 RECEPTOR;

ADULT; ARTICLE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CELL CONTACT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; LOW DRUG DOSE; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REMISSION; TH1 CELL; CASE CONTROL STUDY; CELL COMMUNICATION; CELLULAR IMMUNITY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TH2 CELL;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CELL COMMUNICATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-13; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-12; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

EID: 77951945881     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3005     Document Type: Article

References (26)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999, 341:1284-1291. 10.1056/NEJM199910213411707, 10528040.
2. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 2004, 50:2291-2295. 10.1002/art.20334, 15248229.
3. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999, 42:1967-1974. 10.1002/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z, 10513814.
4. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005, 139:371-378. 10.1111/j.1365-2249.2005.02695.x, 1809277, 15654837.
5. Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko H, Ikeda Y, Kuwana M. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 2004, 50:3658-3662. 10.1002/art.20597, 15529349.
6. Yasuoka H, Yamaguchi Y, Mizuki N, Nishida T, Kawakami Y, Kuwana M. Preferential activation of circulating CD8+ and γδ T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol 2008, 26:S59-S63.
7. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood γδ+ T cells and natural killer cells in Behçet's disease. J Rheumatol 1992, 19:588-592.
8. Kaneko F, Takahashi Y, Muramatsu R, Adachi K, Miura Y, Nakane A, Minagawa T. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol 1985, 113:313-318. 10.1111/j.1365-2133.1985.tb02083.x, 4063167.
9. Hamzaoui K, Ayed K, Hamza M, Touraine JL. Natural killer cells in Behcet's disease. Clin Exp Immunol 1988, 71:126-131. 1541639, 3258201.
10. Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005, 17:29-35. 10.1016/j.coi.2004.11.001, 15653307.
11. Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: do 'NK-reg cells' exist?. Cell Mol Immunol 2006, 3:241-254.
12. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998, 161:5821-5824.
13. Takahashi K, Miyake S, Kondo T, Terao K, Hatakenaka M, Hashimoto S, Yamamura T. Natural killer type 2 bias in remission of multiple sclerosis. J Clin Invest 2001, 107:R23-R29. 10.1172/JCI11819, 199428, 11238569.
14. Wei H, Zhang J, Xiao W, Feng J, Sun R, Tian Z. Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 2005, 115:841-847. 10.1016/j.jaci.2004.11.026, 15806008.
15. Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa T, Kawakami Y, Kuwana M. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol 2007, 127:324-330. 10.1038/sj.jid.5700527, 16946717.
16. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080. International Study Group for Behçet's Disease.
17. Mizuki N, Ohno S, Ando H, Chen L, Palimeris GD, Stavropoulos-Ghiokas E, Ishihara M, Goto K, Nakamura S, Shindo Y, Isobe K, Ito N, Inoko H. A strong association of HLA-B*5101 with Behçet's disease in Greek patients. Tissue Antigens 1997, 50:57-60. 10.1111/j.1399-0039.1997.tb02835.x, 9243757.
18. López-Cebrera M, Santis AG, Fernández-Ruiz E, Blacher R, Esch F, Sánchez-Mateos P, Sánchez-Madrid F. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993, 178:537-547. 10.1084/jem.178.2.537, 2191117, 8340758.
19. Image/J® software. , http://rsb.info.nih.gov/ij/index.html
20. Chua AO, Wilkinson VL, Presky DH, Gubler U. Cloning and characterization of a mouse IL-12 receptor-beta component. J Immunol 1995, 155:4286-4294.
21. Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004, 127:1917-1927. 10.1093/brain/awh219, 15229129.
22. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol 2000, 164:3563-3572.
23. Loza MJ, Peters SP, Zangrilli JG, Perussia B. Distinction between IL-13+ and IFN-γ+ natural killer cells and regulation of their pool size by IL-4. Eur J Immunol 2002, 32:413-423. 10.1002/1521-4141(200202)32:2<413::AID-IMMU413>3.0.CO;2-X, 11813160.
24. Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003, 171:2366-2373.
25. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santani A, Lanier LL. NK cell regulation of T cell-mediated responses. Mol Immunol 2005, 42:451-454. 10.1016/j.molimm.2004.07.025, 15607797.
26. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y. Activation of NK cell cytotoxicity. Mol Immunol 2005, 42:501-510. 10.1016/j.molimm.2004.07.034, 15607806.